Identification of HLA-CW3, GNAS and IMPA as Cytotoxic T-Lymphocyte (CTL) Target Antigens Using an Allogeneic Mixed Lymphocyte Tumor Cell Culture (MLTC) System and Subsequent cDNA Library Screening

2007 ◽  
Vol 22 (2) ◽  
pp. 206-222 ◽  
Author(s):  
Joanne M. Wroblewski ◽  
John R. Yannelli
1980 ◽  
Vol 132 (3) ◽  
pp. 267-276
Author(s):  
YOSHIKI KURIYA ◽  
TETSURO NISHIHIRA ◽  
SHOZO MORI ◽  
TOSHIO WATANABE ◽  
TAIJI SASAKI ◽  
...  

2015 ◽  
Vol 6 ◽  
Author(s):  
Ladislav Dokládal ◽  
David Honys ◽  
Rajiv Rana ◽  
Lan-Ying Lee ◽  
Stanton B. Gelvin ◽  
...  

1987 ◽  
Vol 5 (12) ◽  
pp. 1912-1921 ◽  
Author(s):  
J A Ajani ◽  
F L Baker ◽  
G Spitzer ◽  
A Kelly ◽  
W Brock ◽  
...  

The newly described adhesive tumor cell culture system (ATCCS) offers a distinct advantage over other assays in that it has a high plating efficiency requiring low cell inoculum, it affords workable assays in approximately 70% of specimens from the heterogenous tumor types, and it has the ability to assay up to nine drugs at four different concentrations. Clinical correlations based on the ATCCS were obtained in 65 patients undergoing 71 clinical trials. Patients with melanoma, lung cancer, and sarcoma dominated the group. The most active in vitro drug was correlated per clinical trial. Thirteen of 17 (76%) sensitive in vitro predictions and 51 of 54 (94%) resistant in vitro predictions were accurate. The assay in this study had a sensitivity of 81% and specificity of 93%. These preliminary results are encouraging and warrant prospective trials to establish the true value of this assay to patients.


2016 ◽  
Vol 7 (13) ◽  
pp. 1867-1876 ◽  
Author(s):  
Korkiat Theerakitthanakul ◽  
Jirakrit Saetang ◽  
Jirasak Kruatong ◽  
Potchanapond Graidist ◽  
Pritsana Raungrut ◽  
...  

2006 ◽  
Vol 1 (2) ◽  
pp. 624-632 ◽  
Author(s):  
Kenneth H Wan ◽  
Charles Yu ◽  
Reed A George ◽  
Joseph W Carlson ◽  
Roger A Hoskins ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document